Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.510
-0.010 (-0.66%)
At close: Jul 18, 2025, 4:00 PM
1.500
-0.010 (-0.66%)
After-hours: Jul 18, 2025, 6:32 PM EDT
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $64.77 million as of July 18, 2025. Its market cap has decreased by -54.18% in one year.
Market Cap
64.77M
Enterprise Value
-57.66M
1-Year Change
-54.18%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $64.77M, a decrease of -93.15%. That is a compound annual growth rate of -41.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 65.19M | 17.07% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.42B |
| Johnson & Johnson | 393.56B |
| AbbVie | 338.71B |
| Novo Nordisk | 292.40B |
| UnitedHealth Group | 261.64B |
| Novartis AG | 227.25B |
| AstraZeneca | 214.46B |
| Abbott Laboratories | 210.78B |